Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.48
-1.00 (-4.43%)
At close: Nov 4, 2024, 4:00 PM
20.51
-0.97 (-4.52%)
After-hours: Nov 4, 2024, 6:13 PM EST
KNSA Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -9.07 | 14.08 | 183.36 | -157.92 | -161.38 | -161.87 | |
| Depreciation & Amortization | 1.84 | 2.34 | 2.4 | 2.36 | 2.41 | 2.07 | |
| Loss (Gain) From Sale of Assets | -0.02 | 0.18 | 0.03 | 0.1 | - | 0.02 | |
| Loss (Gain) From Sale of Investments | -0.67 | -1.07 | -0.08 | 0.66 | 0.12 | -3.5 | |
| Stock-Based Compensation | 30.17 | 27.15 | 25.12 | 25.17 | 20.88 | 15.08 | |
| Other Operating Activities | -11.31 | -30.73 | -182.45 | 2.64 | 5.76 | 6.86 | |
| Change in Accounts Receivable | -21.85 | -0.95 | -16.33 | -3.91 | - | - | |
| Change in Inventory | -3.1 | -9.52 | -17.92 | -3.68 | - | - | |
| Change in Accounts Payable | 7.21 | 0.35 | 6.03 | 1.37 | -4.97 | -4.71 | |
| Change in Unearned Revenue | -2.63 | 0.26 | 12 | - | - | - | |
| Change in Other Net Operating Assets | 20.67 | 11.22 | -6.35 | 6.91 | 0.65 | -12.32 | |
| Operating Cash Flow | 11.24 | 13.3 | 5.81 | -126.3 | -136.53 | -158.37 | |
| Operating Cash Flow Growth | - | 129.05% | - | - | - | - | |
| Capital Expenditures | -0.14 | -0.13 | -0.11 | -0.42 | -0.28 | -3.2 | |
| Sale of Property, Plant & Equipment | 0.03 | - | 0.09 | - | - | - | |
| Sale (Purchase) of Intangibles | - | - | - | -20 | - | - | |
| Investment in Securities | -42.4 | -29.43 | -8.06 | 149.05 | -23.16 | 52.42 | |
| Investing Cash Flow | -42.52 | -29.56 | -8.08 | 128.64 | -23.44 | 49.21 | |
| Issuance of Common Stock | 15.49 | 3.7 | 3.42 | 5.89 | 228.22 | 84.23 | |
| Repurchase of Common Stock | -4.67 | -2.21 | -0.9 | - | - | - | |
| Other Financing Activities | - | - | - | - | -1.14 | -0.12 | |
| Financing Cash Flow | 10.82 | 1.5 | 2.52 | 5.89 | 227.09 | 84.11 | |
| Net Cash Flow | -20.45 | -14.76 | 0.25 | 8.22 | 67.11 | -25.05 | |
| Free Cash Flow | 11.1 | 13.17 | 5.7 | -126.71 | -136.82 | -161.57 | |
| Free Cash Flow Growth | - | 130.99% | - | - | - | - | |
| Free Cash Flow Margin | 2.89% | 4.87% | 2.59% | -328.75% | - | - | |
| Free Cash Flow Per Share | 0.16 | 0.18 | 0.08 | -1.85 | -2.21 | -2.99 | |
| Cash Income Tax Paid | - | 5.61 | 10.69 | 1.28 | 0.48 | 1.72 | |
| Levered Free Cash Flow | 25.74 | 13.79 | -2.36 | -83.56 | -73.27 | -110.5 | |
| Unlevered Free Cash Flow | 25.74 | 13.79 | -2.36 | -83.56 | -73.27 | -110.5 | |
| Change in Net Working Capital | -10.27 | -0.17 | 35.89 | -7.23 | -2.09 | 18.22 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.